Bharat Biotech

New Delhi: Covaxin manufacturer Bharat Biotech has warned people who are immuno-compromised or are on medicines that affect the immune system to not take the jab, according to a detailed factsheet released by the manufacturer. The…

Mumbai: The debate over Bharat Biotech-manufactured Covaxin continues. A writ plea has been moved before the Bombay High Court seeking direction to the Drugs Controller General of India (DCGI) to bring all information regarding safety and…

New Delhi: Those receiving Bharat BioTech’s Covaxin during the nationwide vaccination drive against COVID-19 will have to sign a “consent form” and agree to certain terms and conditions. Besides, the recipients of Covaxin will be…

New Delhi: Amid criticism of what many consider to be ‘premature’ emergency use approval given to Bharat Biotech’s Covaxin, a senior scientist of Indian Council of Medical Research (ICMR) vouched for the safety of the indigenously developed…

New Delhi: Following reports of a volunteer’s demise during its Phase 3 vaccine trials, Bharat Biotech on Saturday cited cardio respiratory failure due to suspected poisoning as the probable cause of death. The statement they issued also…

New Delhi: The logistics for storing all Indian vaccines being developed against the coronavirus at 2-8 degrees Celsius have been worked out while considering temperature as a factor, 'mint' quoted Secretary, Department of Biotechnology…

New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed confidence at a press conference on Monday. According to Bharat Biotech chairman and managing…

Surat: With the Congress raising doubts over the efficacy of COVID-19 vaccine, Union Minister Dharmendra Pradhan termed people with such mentality as 'mandh buddhi'. The Union Minister said those doubting efficacy of Bharat Biotech's…

New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield, manufactured by Pune-based Serum Institute of India (SII)…

New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval to Covaxin. AIDAN has said it is shocked to learn about…